Adding Heparin to Aspirin Reduces the Incidence of Myocardial Infarction and Death in Patients With Unstable Angina
- 11 September 1996
- journal article
- review article
- Published by American Medical Association (AMA) in JAMA
- Vol. 276 (10) , 811-815
- https://doi.org/10.1001/jama.1996.03540100055028
Abstract
Objective. —To estimate the risk of myocardial infarction (MI) and death in patients with unstable angina who are treated with aspirin plus heparin compared with patients treated with aspirin alone. Data Sources. —Studies were retrieved using MEDLINE, bibliographies, and consultation with experts. Study Selection. —Only published trials that enrolled patients with unstable angina, randomized participants to aspirin plus heparin vs aspirin alone, and reported incidence of myocardial infarction or death were included in the meta-analysis. Data Extraction. —Patient outcomes including MI or death, recurrent ischemic pain, and major bleeding during randomized treatment; revascularization procedures after randomization; and MI or death during the 2 to 12 weeks following randomization were extracted by 2 authors, 1 of whom was blinded to the journal, institution, and author of each study. Data Synthesis. —Six randomized trials were included. The overall summary relative risk (RR) of MI or death during randomized treatment was 0.67 (95% confidence interval [CI], 0.44-1.02) in patients with unstable angina treated with aspirin plus heparin compared with those treated with aspirin alone. The summary RRs for secondary endpoints in patients treated with aspirin plus heparin compared with those treated with aspirin alone were 0.68 (95% CI, 0.40-1.17) for recurrent ischemic pain; 0.82 (95% CI, 0.56-1.20) for MI or death 2 to 12 weeks following randomization; 1.03 (95% CI, 0.74-1.43) for revascularization; and 1.99 (95% CI, 0.52-7.65) for major bleeding. We found no statistically significant heterogeneity among individual study findings. Conclusions. —Our findings are consistent with a 33% reduction in risk of MI or death in patients with unstable angina treated with aspirin plus heparin compared with those treated with aspirin alone. The bulk of evidence suggests that most patients with unstable angina should be treated with both heparin and aspirin.Keywords
This publication has 9 references indexed in Scilit:
- Heparin: Mechanism of Action, Pharmacokinetics, Dosing Considerations, Monitoring, Efficacy, and SafetyChest, 1995
- LOW MOLECULAR WEIGHT HEPARIN(S)British Journal of Haematology, 1995
- Review papers : The statistical basis of meta-analysisStatistical Methods in Medical Research, 1993
- Reactivation of Unstable Angina after the Discontinuation of HeparinNew England Journal of Medicine, 1992
- Usefulness of antithrombotic therapy in resting angina pectoris or non-Q-wave myocardial infarction in preventing death and myocardial infarction (a pilot study from the antithrombotic therapy in acute coronary syndromes study group)The American Journal of Cardiology, 1990
- A comparison of statistical methods for combining event rates from clinical trialsStatistics in Medicine, 1989
- Insights into the pathogenesis of acute ischemic syndromes.Circulation, 1988
- Coronary bypass surgery for unstable angina.Circulation, 1984
- Actions and Interactions of Antithrombin and HeparinNew England Journal of Medicine, 1975